Understanding how HIV integrates into human DNA
Project 3. Integration
This study is looking at how HIV mixes its genetic material with our cells' DNA, which could help us understand the virus better and find new ways to treat it, so it's especially for people living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11078372 on NIH RePORTER |
What this research studies
This research investigates the process by which HIV integrates its genetic material into the DNA of human cells. By examining the structure and function of the viral integration machinery, the study aims to uncover how HIV interacts with host cell DNA and the role of specific proteins in this process. Patients may benefit from insights gained into the mechanisms of HIV replication, which could lead to improved treatments or therapies. The research employs advanced techniques such as DNA footprinting and microscopy to analyze the integration process in detail.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are interested in understanding the mechanisms of their infection and potential new treatment options.
Not a fit: Patients who are not infected with HIV or those who have already achieved long-term viral suppression may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating HIV infections.
How similar studies have performed: Previous research has shown success in understanding viral integration mechanisms, but this specific approach using advanced techniques is relatively novel.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Cherepanov, Peter — University of Pittsburgh at Pittsburgh
- Study coordinator: Cherepanov, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.